CRI Lifetree Opens New Early Stage Research Facility
(Mount Laurel, NJ; July 10, 2012) – CRI Lifetree opened a new state-of-the-art, early stage research facility in Marlton, N.J. The new site raises the company’s total bed count to 250 and adds capacity to conduct complex clinical trials.
CRI Lifetree, a leader in specialized early stage research focused in pain, human abuse liability, psychiatry, neurology and diabetes, announced its new location to the drug development industry at the 2012 Drug Information Association (DIA) Annual Meeting held June 24-28 in Philadelphia.
“Because our facility is so close to Philadelphia, DIA gave us the opportunity to show many clients the site firsthand. The feedback was overwhelmingly positive!” noted Larry Brownstein, CRI Lifetree’s head of corporate development.
Brownstein added, “The recent visitors were pleased to see we have expanded our research space with this new, 60-bed, purpose-built facility.”
The additional bed space and added capabilities for conducting complex neurology, pediatrics and normal healthy patient studies comes at a time of considerable need for the industry. Other facility features include six beds dedicated to first-in-human studies. This space has an observation area to allow clinicians and sponsors the access needed. The new center also has separate areas for elderly and pediatric populations. The 21,000-square-foot building adds to CRI Lifetree’s two other facilities in Philadelphia and Salt Lake City.
CRI Lifetree, formerly CRI Worldwide and Lifetree Clinical Research®, is a leader in specialized, multitherapeutic inpatient and outpatient early stage research.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
